CTRC Seminar Series


The goal of the CTRC seminar series is to promote interactions between world-renowned invited speakers and cancer center members to foster collaborative science that will benefit the health of the population we serve. Refreshments will be served.

2012 - 2013 CTRC Seminar Series Speakers

Wednesday, October 3, 2012
Michael Lewis, Ph.D.
Modeling Mammary Gland Development and Breast Cancer

Wednesday, October 9, 2012
Jonathan Yingling, Ph.D.
LY2157299, A First-in-Class TGFbeta Type 1 Receptor Inhibitor

Wednesday, October 10, 2012
Paraskevi Giannakakou, Ph.D.
Functional Studies of Circulating Tumor Cells to Elucidate the Molecular Basis of Clinical Resistance in Prostate Cancer

Wednesday, October 24, 2012
Lee Kraus, Ph.D.

Monday, November 12, 2012
Jingwu Xie, Ph.D.
Molecular basis of hedgehog signaling-mediated carcinogenesis and the clinical implications

Monday, December 03, 2012
Robert Quinn, Ph.D.

Monday, January 14, 2013
David Foster, Ph.D.
Phospholipase D-mTOR Survival Signals in Cancer Cells

TBD, 2013
Cheryl Wilman, Ph.D.

Monday, March 11, 2013
David Ross, Ph.D.
Novel quinoid antitumor agents targeting Hsp90 and thioredoxin reductase

Monday, April 8, 2013
Richard Eckert, Ph.D.
Making Sense of Skin - The Impact of Natural Dietary Agents on Skin Cancer Cell Survival

Monday, May 13, 2013
Emily Scott, Ph.D.

Monday, June 10, 2013
Andy Dannenburg, Ph.D.
The Obesity-Inflammation Connection: Implications for Breast Cancer